CompanyNasdaqRadnor, PA

Certara, Inc

Certara develops biosimulation software and services for drug discovery and development.

SEC EDGAR ClinicalTrials.gov

10-QNov 5Latest SEC filing

Form DMar 27Private placement

November 2026

Certara narrows 2026 revenue growth outlook as software revenue grows 11% in third quarter

Nov 5Quarterly updateCertara, Inc